Avenue Therapeutics, Inc.
ATXI
$0.773
-$0.1725-18.24%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.74M | 5.08M | 4.51M | 4.18M | 6.41M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.81M | 10.72M | 11.82M | 14.54M | 16.33M |
| Operating Income | -11.81M | -10.72M | -11.82M | -14.54M | -16.33M |
| Income Before Tax | -9.52M | -5.92M | -7.24M | -10.49M | -10.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.52 | -5.92 | -7.24 | -10.49 | -10.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 52.00K | 54.00K | 54.00K | 111.00K | 139.00K |
| Net Income | -9.47M | -5.87M | -7.18M | -10.38M | -10.44M |
| EBIT | -11.81M | -10.72M | -11.82M | -14.54M | -16.33M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -21.46 | -14.67 | -46.98 | -133.15 | -125.68 |
| Normalized Basic EPS | -6.05 | -1.77 | -24.45 | -82.77 | -77.81 |
| EPS Diluted | -21.46 | -14.67 | -46.98 | -133.15 | -125.75 |
| Normalized Diluted EPS | -6.05 | -1.77 | -24.45 | -82.77 | -77.81 |
| Average Basic Shares Outstanding | 3.56M | 2.07M | 1.05M | 564.50K | 344.70K |
| Average Diluted Shares Outstanding | 3.56M | 2.07M | 1.05M | 564.50K | 344.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
